D-amino Acid Oxidase Activity Research Articles

Carving Chaos: Genetics and the Classification of Mood and Psychotic Syndromes

Though Kraepelin's century-old division of major mental illness into mood disorder and schizophrenia remains in place, debate abounds over the most appropriate classification. Although these arguments previously rested solely on clinical grounds, they now are rooted in genetics and neurobiology. This article reviews evidence from the fields of genetic epidemiology, linkage, association, cytogenetics, and gene expression. Taken together, these data suggest some overlap in the genes that predispose to bipolar disorder and schizophrenia. One gene, DAOA (D-amino acid oxidase activator, also known as G72), has been repeatedly implicated as an overlap gene, while DISC1 and others may constitute additional shared susceptibility genes. Further, some evidence implicates syndromes of co-occurring mood and psychotic symptoms in association with the putative risk alleles in overlap genes. From a nosologic perspective, the existence of overlap genes, coupled with the genotype-phenotype correlations discovered to date, supports the reality of the much debated schizoaffective disorder. Potential non-overlap syndromes--such as nonpsychotic bipolar disorder or cyclothymic temperament, on the one hand, and negative symptoms or the deficit syndrome, on the other--could turn out to have their own unique genetic determinants. If genotypes are to be the anchor points of a clinically useful system of classification, they must ultimately be shown to inform prognosis, treatment, and prevention. No gene variants have yet met these tests in bipolar disorder or schizophrenia.

An update on the genetics of schizophrenia

This paper reviews recent molecular genetic studies of schizophrenia and evaluates claims implicating specific genes as susceptibility loci. Molecular genetic studies have identified several potential regions of linkage and two associated chromosomal abnormalities, and the evidence is accumulating in favour of several positional candidate genes. Currently, the strongest evidence for putative schizophrenia susceptibility loci relates to the genes encoding dysbindin (DTNBP1) and neuregulin (NRG1). For other genes, disrupted in schizophrenia (DISC1), D-amino acid oxidase activator (DAOA), regulator of G-protein signalling 4 (RGS4) and V-AKT murine thymoma viral oncogene homolog 1 (AKT1) the data are promising but not yet compelling. In the most convincing cases, the risk haplotypes appear to be associated with small effect sizes and do not fully explain the linkage findings that prompted each study. The ability of positional genetics to implicate novel genes and pathways will open up new vistas for neurobiological research. Despite the accumulation of significant genetic data, however, the susceptibility variants have yet to be identified and detailed follow-up studies are now required.

Potential Role for Astroglial d-Amino Acid Oxidase in Extracellular d-Serine Metabolism and Cytotoxicity

D-amino acid oxidase (DAO) is a flavoenzyme that catalyzes the oxidation of D-amino acids. In the brain, gene expression of DAO is detected in astrocytes. Among the possible substrates of DAO in vivo, D-serine is proposed to be a neuromodulator of the N-methyl-D-aspartate (NMDA) receptor. In a search for the physiological role of DAO in the brain, we investigated the metabolism of extracellular D-serine in glial cells. Here we show that after D-serine treatment, rat primary type-1 astrocytes exhibited increased cell death. In order to enhance the enzyme activity of DAO in cells, we established stable rat C6 glial cells overexpressing mouse DAO designated as C6/DAO. Treatment with a high dose of D-serine led to the production of hydrogen peroxide (H(2)O(2)) followed by apoptosis in C6/DAO cells. Among the amino acids tested, D-serine specifically exhibited a significant cell death-inducing effect. DAO inhibitors, i.e., sodium benzoate and chlorpromazine, partially prevented the death of C6/DAO cells treated with D-serine, indicating the involvement of DAO activity in d-serine metabolism. Overall, we consider that extracellular D-serine can gain access to intracellular DAO, being metabolized to produce H(2)O(2). These results support the proposal that astroglial DAO plays an important role in metabolizing a neuromodulator, D-serine.

Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia

There are several lines of evidence suggesting that the regulation of D-aminoacids may play a role in development or modulation of schizophrenia. First, endogenous D-aspartate and D-serine have been recently found in mammalian nervous system. The D-serine is enriched in brain, particularly in prefrontal and parietal cortex, regions implicated in the pathogenesis of schizophrenia.1 Second, D-serine has potency as an endogenous coagonist at the glycine site of NMDA receptors. The hypofunction of NMDA receptor-mediated neurotransmission may contribute to development of schizophrenia.2, 3 Third, the genetic role of the G72 gene for the putative protein termed D-amino-acid oxidase activator (DAOA) and the gene for D-amino-acid oxidase (DAAO) were recently implicated in schizophrenia.4 The original genetic association between SNPs and haplotypes in DAOA and schizophrenia was supported by at least several subsequent studies of other case–control groups including schizophrenia and other psychiatric illnesses.5, 6 The data implicate that genes for proteins involved in metabolism of D-amino-acids, modulators of NMDA receptors, might potentially contribute to schizophrenia pathogenesis. The gene for mammalian serine racemase that catalyses the synthesis of D-serine from L-serine was recently described.7 We searched for variations in the 5'-promoter region of gene for human serine racemase located at 17p13 and characterized a common SNP in this region that may affect putative transcriptional regulatory sites. We examined the frequency of this SNP in schizophrenics and control individuals collected in Moscow. The original case–control sample was composed of 234 schizophrenic patients and 251 control individuals from Russia. The patients were recruited from psychiatric hospitals in Moscow. The control samples were from blood donors from Moscow with no psychiatric illnesses according to the medical records. The diagnosis of schizophrenia was made in accordance with International Classification of Disorders 10 (ICD-10) criteria. All patients in this study met criteria for paranoid schizophrenia (F20.0 in ICD-10). DNA was extracted from peripheral venous blood specimens using the phenol–chloroform method. We analyzed the polymorphism found in 5'-promoter region of serine racemase gene (G/C SNP at the 12 bp upstream of the most 5'-site of the mRNA SRR transcript, SNP at the position 2124325 NT_086857.1, dbSNP:408067). Screening of the 5'-region of the SRR (3100 bp) gene for putative regulatory sites using the MatInspector program from the Genomatix Software server (http://www.genomatix.de) identified that the short sequence stretch (gcgcagcG/Ccccgcccgccccaccc) harboring the G/C polymorphism similar to regulatory sequence elements for early growth factor response 1 (EGR1), activator protein 2 and other putative transcriptional factors. Direct and reverse primer oligonucleotides were designed for the polymorphic region to generate a PCR product of 329 bp and for the genotyping by DNA restriction analysis (HaeII endonuclease). Association analysis between the SNP allele or genotypes and schizophrenia were performed by exact tests and 2-test. Observed genotype frequencies showed no deviation from Hardy–Weinberg equilibrium in control and case samples (Table 1). The frequency of the genotypes showed that although the 5'-G/C SRR polymorphism is obviously not a major risk factor for schizophrenia, the modest contribution of the genotypes as a protective or vice versa disease risk factors have to be considered further. The statistically significant prevalence of the G allele was found in the total group of paranoid schizophrenia from the Moscow population group (Ms cohort) (P=0.024, OR=1.361, C.I.=1.042–1.777). The GG genotype was a more frequent than CC genotype in schizophrenia versus control (P=0.047, OR=1.774, C.I.=1.005–3.132). However, when several individuals with self-proxy determined non-Russian ethnicity (6% in the total Moscow schizophrenia sample) were excluded from the analysis (Ms-r cohort) the association between G allele and schizophrenia failed to reach the statistically significant value (P=0.068, OR=1.288, C.I.=0.981–1.690). The data demonstrate that minor ethnic heterogeneity or reduced power may affect the genetic association data, which are at the borderline significance. The stratification of schizophrenia group by age and gender had no significant effect on the results (Table 1). When the data were in preparation for publication other group reported no significant association between polymorphisms in SRR gene and schizophrenia in Japanese population.8 Although the 5'-SRR polymorphism alone is unlikely to be a strong risk factor for paranoid schizophrenia the etiology of schizophrenia may depend on a combination of variations in genes for proteins involved in metabolism of D-aminoacids or D-amino-acid regulated NMDA receptor signaling. The study of synergistic effects of biologically meaningful variations in genes involved in this pathway may be a promising strategy to define genetic risk factors for schizophrenia.

Screening of d-amino acid oxidase inhibitor by a new multi-assay method

This paper describes an investigation of the inhibition of a d-amino acid oxidase (DAAO) activity in several kinds of food additives and fruit. To screen for an inhibitor of DAAO, the method employed checked for two kinds of indicators, namely, pyruvic acid (indicator-1) and hydrogen peroxide (indicator-2), both of which are formed by digestion by DAAO of d-alanine (the standard d-amino acid used in this study). For measurement of pyruvic acid, a reliable and authenticated method was employed: the presence of pyruvic acid was determined by converting it into a chromophore derivative by tagging with 2,4-dinitro phenylhydrazine (DNP), followed by measurement of absorbance at 445 nm. The pyruvic acid thus determined is referred to as “(colorimetric) indicator-1”. To measure hydrogen peroxide, a highly sensitive fluorogenic substrate, 3-( p-hydroxyphenyl)propionic acid (HPPA), was employed in the present study. Hydrogen peroxide was detected by measuring fluorescence intensity (Ex. = 320 nm, Em. = 405 nm) of 2,2′-dihydroxybipheny l-5,5′-dipropionic acid (oxidize-HPPA), which is produced by horseradish peroxidase (HRP)-catalyzed oxidation of HPPA with hydrogen peroxide. The hydrogen peroxide thus determined is referred to as “(flourometric) indicator-2” After optimizing the multi-assay procedures, the inhibition of DAAO activity against d-alanine (used as the standard d-amino acid) in 11 kinds of food additives and five kinds of fruit was evaluated, first in terms of indicator-1. Then, two substrates, potassium sorbate and apple juice, that were screened by indicator-1, were further evaluated by indicator-2 to conform the inhibition of DAAO activity. This is the first demonstration of the inhibition of DAAO activity by potassium sorbate, which is widely used as a synthetic preservative in food and apple juice.

Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells

d-Serine indirectly caused dose- and time-dependent inhibition of neuronal nitric oxide synthase (nNOS) without affecting endothelial nitric oxide synthase (eNOS) in human glioblastoma cell line U87. Activity of d-amino acid oxidase (DAAO), catalyzing the oxidative deamination of d-amino acid, was enhanced by NO in a dose-dependent manner. Recently, we have reported that serine racemase (SR) is inhibited by NO and activated by d-serine through nitrosylation and denitrosylation, respectively [K. Shoji, S. Mariotto, A.R. Ciampa, H. Suzuki, Regulation of serine racemase activity by d-serine and nitric oxide in human glioblastoma cells, Neurosci. Lett., in press]. Thus, the metabolism of both d-serine and NO in U87 cells is functionally correlated in a complex manner. Suppression of NO production by d-serine in U87 cells contrasts its known action in enhancing nNOS in neurons.

Genotype-Phenotype Studies in Bipolar Disorder Showing Association Between the DAOA/G30 Locus and Persecutory Delusions: A First Step Toward a Molecular Genetic Classification of Psychiatric Phenotypes

The authors previously reported an association between the D-amino acid oxidase activator (DAOA)/G30 locus and both schizophrenia and bipolar affective disorder. Given the presumed role of DAOA/G30 in the neurochemistry of psychosis and its localization in a schizophrenia and bipolar affective disorder linkage region (13q34), it was hypothesized that the bipolar affective disorder finding would be mainly due to an association with psychotic features. The marker/haplotype associations obtained in a subset of 173 bipolar affective disorder patients with psychotic features were similar to those in the overall patient group, suggesting that stratification on the basis of psychotic features in general might be too crude a procedure. The authors therefore tested whether confining caseness to specific psychotic features would improve detection of genotype-phenotype correlations. In a logistic regression, "persecutory delusions" were found to be the only significant explanatory variable for the DAOA/G30 risk genotype among 21 OPCRIT symptoms of psychosis. The authors therefore tested for association between DAOA/G30 and bipolar affective disorder in the 90 cases with a history of persecutory delusions. Whereas this subset showed strong association (odds ratio=1.83 for the best marker), the remaining larger sample of 165 patients with no such history did not differ from comparison subjects, suggesting that the association between DAOA/G30 and bipolar affective disorder is due to persecutory delusions. This was confirmed in an independent study of 294 bipolar affective disorder patients and 311 comparison subjects from Poland, in which an association between bipolar affective disorder and DAOA/G30 was only seen when case definition was restricted to cases with persecutory delusions. These data suggest that bipolar affective disorder with persecutory delusions constitutes a distinct subgroup of bipolar affective disorder that overlaps with schizophrenia.

Expression in Escherichia coli and in vitro refolding of the human protein pLG72

Recently, genes coding for pLG72 and d-amino acid oxidase have been related to schizophrenia, a widespread psychiatric disorder that affects about 1% of population. pLG72 is a puzzling, novel protein present only in primates and proposed to be an activator of d-amino acid oxidase. Here we report on the overexpression of wild-type and His-tagged pLG72 in Escherichia coli. Both variants form inclusion bodies and have been refolded and purified to homogeneity: the acquisition of secondary and tertiary structure was demonstrated by CD spectroscopy. A figure of ∼70 mg of pure protein per liter of fermentation broth was achieved.

Sensitive high-performance liquid chromatographic assay for d-amino-acid oxidase activity in mammalian tissues using a fluorescent non-natural substrate, 5-fluoro- d-tryptophan

A sensitive assay for d-amino-acid oxidase (DAO) activity in mammalian tissues has been established. d-Tryptophan ( d-Trp) analogs were tested as substrates for DAO, and 5-fluoro- d-tryptophan ( d-FTP) was found to be the best substrate. By the enzymatic reaction, d-FTP was converted to 5-fluoroindole-3-acetic acid (FIAA), a highly fluorescent product, and the product was determined by an RP-HPLC system with a fluorescence detector. The detection limit for purified DAO (from hog kidney) was 0.25 μU, and the within-day and day-to-day precisions of the assays were 4.6% (RSD, n = 5), and 13.8% (RSD, 5 days), respectively. By the present method, the detailed distribution of DAO activity in the mouse brain was determined using individual animals for the first time, and significant activities were observed in the cerebellum, medulla oblongata and midbrain. Because sensitive DAO assay is frequently required in small tissues or in limited-tissue regions, the present method is useful for various research studies concerning DAO and the related d-amino acids.

Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801

The behavioral effects produced by MK-801 (0.4 mg/kg) were compared in mutant DAO−/− mice lacking d-amino acid oxidase activity and normal DAO+/+ mice. Mutant mice display marked diminution of stereotypy and ataxia induced by MK-801 compared to normal mice. Because the d-serine level in the brain of mutant mice is significantly higher than that of normal mice, the elevated d-serine in the brain of mutant mice could antagonize MK-801-induced stereotypy and ataxia.

Bipolar Disorder with Persecutory Delusions: A Specific Genotype

Among the linkage areas implicated in bipolar disorder and schizophrenia is chromosome locus 13q34. Previous research has demonstrated an association of the D-amino acid oxidase activator (DAOA/G30) locus found there with both disorders. To see whether the presence of psychotic features would provide greater specificity for this association in bipolar disorder, the authors …

Physiological Function and Metabolism of Free D-Alanine in Aquatic Animals

Aquatic crustaceans and some bivalve mollusks contain a large amount of free D-alanine (up to 100 mumol/g wet wt.) in their tissues. Under high salinity stress, crustaceans and bivalve mollusks largely accumulate D- and L-alanine irrespective of species examined, together with L-glutamine, L-proline, and glycine of which increases are species dependent. These data indicate that D-alanine is one of the major compatible osmolytes responsible for the intracellular isosmotic regulation in the tissues of crustaceans and bivalves. Alanine racemase has been proven to catalyze the interconversion of D- and L-alanine in these invertebrates. The enzyme has been isolated to homogeneity from the muscle of black tiger prawn Penaeus monodon and its cDNA has been cloned from the muscle and hepatopancreas of kuruma prawn Penaeus japonicus for the first time in eukaryotes other than yeast. Several fish species fed on crustaceans and mollusks contain D-amino acid and D-aspartate oxidases that catalyze the decomposition of D-amino acids. A cDNA of D-amino acid oxidase has been cloned from the hepatopancreas of omnivorous common carp Cyprinus carpio. During oral administration of free D-alanine to carp, the activity and mRNA of D-amino acid oxidase increased rapidly in hepatopancreas and the increases were highest in intestine followed by hepatopancreas and kidney. These data suggest that D-amino acid oxidase is inducible in carp and an important enzyme responsible for the efficient utilization of carbon skeleton of D-alanine in their feeds.

Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity

Mammalian brain contains high levels of d-serine, an endogenous co-agonist of N-methyl D-aspartate type of glutamate receptors. D-Serine is synthesized by serine racemase, a brain enriched enzyme converting L- to D-serine. Degradation of D-serine is achieved by D-amino acid oxidase, but this enzyme is not present in forebrain areas that are highly enriched in D-serine. We now report that serine racemase catalyzes the degradation of cellular D-serine itself, through the alpha,beta-elimination of water. The enzyme also catalyzes water alpha,beta-elimination with L-serine and L-threonine. alpha,beta-Elimination with these substrates is observed both in vitro and in vivo. To investigate further the role of alpha,beta-elimination in regulating cellular D-serine, we generated a serine racemase mutant displaying selective impairment of alpha,beta-elimination activity (Q155D). Levels of D-serine synthesized by the Q155D mutant are several-fold higher than the wild-type both in vitro and in vivo. This suggests that the alpha,beta-elimination reaction limits the achievable D-serine concentration in vivo. Additional mutants in vicinal residues (H152S, P153S, and N154F) similarly altered the partition between the alpha,beta-elimination and racemization reactions. alpha,beta-Elimination also competes with the reverse serine racemase reaction in vivo. Although the formation of L- from D-serine is readily detected in Q155D mutant-expressing cells incubated with physiological D-serine concentrations, reversal with wild-type serine racemase-expressing cells required much higher D-serine concentration. We propose that alpha,beta-elimination provides a novel mechanism for regulating intracellular D-serine levels, especially in brain areas that do not possess D-amino acid oxidase activity. Extracellular D-serine is more stable toward alpha,beta-elimination, likely due to physical separation from serine racemase and its elimination activity.

Renal d-Amino Acid Oxidase Mediates Chiral Inversion ofNG-Nitro-d-arginine

N(G)-nitro-d-arginine (d-NNA), i.v. injected into rats, produced a pressor response, and was presumed to act via chiral inversion into N(G)-nitro-l-arginine (l-NNA), an inhibitor of nitric oxide synthase. We examined the possible role of renal d-amino acid oxidase (DAAO) in the chiral inversion of d-NNA to l-NNA. In pentobarbital-anesthetized rats, l-NNA was detected via capillary electrochromatography in the blood immediately after i.v. injection of d-NNA. The time course of appearance of l-NNA paralleled the increase in blood pressure elicited by d-NNA. Unilateral renal ligation partially, and bilateral ligation completely, blocked the pressor response as well as the conversion of d-NNA to l-NNA. Furthermore, injection into conscious rats of sodium benzoate, a selective DAAO inhibitor, completely blocked the pressor response to naive d-NNA, but not pressor response to d-NNA preincubated with homogenates of the kidney. Homogenates of the kidneys, liver (lesser degree), and brain (much lesser degree) converted d-NNA to l-NNA, and the chiral inversion was blocked by the addition of benzoate. Moreover, d-NNA chiral inversion correlates with the activity of DAAO. Our results reveal a novel pathway of chiral inversion of d-amino acids where the renal DAAO plays an essential role that accounts for the biological activity of d-NNA.

Cloning and co-expression of d-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase genes in Escherichia coli

To convert cephalosporin C to 7-aminocephalosporin (7-ACA), a d-amino acid oxidase (DAAO) gene from Trigonopsis variabilis and a glutaryl-7-aminocephalosporanic acid acylase (GL-7-ACA acylase) gene from Pseudomonas were cloned and expressed in recombinant Escherichia coli. For DAAO recombinant strain BL21(DE3)/pET-DAAO, a high DAAO activity of 250 U ml −1 was obtained by a fed-batch culture. A GL-7-ACA acylase gene, in which the signal peptide sequence was deleted, was also successfully expressed in a recombinant E. coli BL21(DE3)/pET-ACY with a high expression level of 3000 U l −1. A novel recombinant strain, BL21(DE3)/pET-DA, harboring both genes of DAAO and GL-7-ACA acylase, was further constructed, and a rather high DAAO activity of 140 U ml −1 and GL-7-ACA acylase activity of 950 U l −1 were simultaneously obtained. This recombinant strain, in which two genes are co-expressed, made it possible to catalyze cephalosporin C into 7-ACA directly.

Construction and application of fusion proteins of D-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase for direct bioconversion of cephalosporin C to 7-aminocephalosporanic acid.

Two fusion proteins of D-amino acid oxidase (DAAO) and glutaryl-7-aminocephalosporanic acid acylase (GLA) were designed to simplify the bioconversion process of cephalosporin C to 7-aminocephalosporanic acid (7-ACA), which is conventionally produced in a two-step enzymatic process. Two recombinant plasmids, pET-DLA and pET-ALD, were constructed to express fusion proteins of DAAO-linker-GLA (DLA) and GLA-linker-DAAO (ALD), respectively. When the recombinant plasmids were expressed in E. coli, the fusion protein DLA was not correctly folded and only DAAO activity could be detected. ALD, however, possessed activities of both DAAO and GLA, which directly catalyze the conversion of cephalosporin C into 7-ACA.

Regulation of D-amino acid oxidase expression in the yeast Rhodotorula gracilis.

Rhodotorula gracilis is a oleaginous yeast which utilizes D-amino acids as a source of carbon and/or nitrogen. D-amino acid oxidase (DAAO), which converts D-amino acids in the corresponding alpha-keto acids and ammonia, is the first enzyme involved in the catabolism of D-amino acids. DAAO activity is induced by the presence of D-alanine, but the presence of the L-isomer prevents induction by inhibiting the transport of D-alanine into cells. To understand how DAAO expression is regulated, R. gracilis cells were grown on media containing different nitrogen and/or carbon sources. As a general rule, the level of DAAO mRNA reached a maximum after 15 h growth and preceded by approximately 6 h the maximum level of DAAO activity. The inducer D-alanine acts by increasing the rate of DAAO mRNA transcription: the increase in DAAO expression is due essentially to de novo synthesis. The presence of a supplemental carbon source (e.g. succinate or glucose) does not repress DAAO expression. Ammonium sulphate appears to have a negative effect on DAAO mRNA translation and on the expression of DAAO activity: DAAO is only partially active when the yeast is grown in the presence of D-alanine and ammonium sulphate. The best expression of DAAO activity was obtained by growing the cells for 12 h at 30 degrees C in the presence of glucose and D-alanine using cells pre-cultured for 10 h on glucose and L-alanine (0.99 U/mg protein, corresponding to approximately 1.0% total proteins in the crude extract). Under these growth conditions a six-fold increase in DAAO production was achieved.

Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.

A positron-emitter (carbon-11) labeled antagonist for the glycine-binding site of NMDA receptors, [(11)C]L-703,717, has a unique in vivo binding characteristic, in which it preferentially binds to cerebellar-specific NMDA receptors consisting of a GluRepsilon3 subunit and eventually accumulates in rodent cerebellum under in vivo conditions, but not under in vitro conditions. In order to understand the in vivo-specific site and subunit localization of this radioligand, we examined the effect of the endogenous glycine site agonists, glycine and D-serine, on in vivo [(11)C]L-703,717 binding. An increase in extracellular glycine concentration by treatment with a glycine transporter 1 (GlyT1)-selective inhibitor, NFPS ethyl ester, significantly decreased the cerebellar localization of [(11)C]L-703,717 in rats. D-serine is known to be concentrated in mammalian forebrain regions. The lack of D-serine detection in the cerebellum may be due to the fact that it has the highest enzymatic activity of D-amino acid oxidase (DAO). It was found that the cerebellar localization of [(11)C]L-703,717 is greatly diminished in mutant mice lacking DAO, in which D-serine content in the cerebellum is drastically increased from a nondetectable level in normal mice. These studies indicate that [(11)C]L-703,717 is susceptible to inhibition by glycine site agonists in its in vivo binding, and suggest that regional differences in inhibitions by endogenous agonists may be a crucial factor in the site- and subunit-specific binding of this glycine-site antagonist.

Coherence of co-familial phenotypes in schizophrenia: Craniofacial dysmorphology, though disorder, and smooth pursuit eye movements

There is a relatively high genetic heritability of schizophrenia as shown by family, twin and adoption studies. A large number of hypotheses on the causes of schizophrenia occurred over time. In this review we focus on genetic findings related to potential alterations of intracellular Ca-homeostasis in association with schizophrenia.First, we provide evidence for the NMDA/glutamatergic theory of schizophrenia including calcium processes. We mainly focus on genes including: DAO (d-amino acid oxidase), DAOA (d-amino acid oxidase activator), DTNBP1 (Dysbindin 1, dystrobrevin-binding protein 1), NRG1 (Neuregulin 1), ERBB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4, avian), NOS1 (nitric oxide synthase 1, neuronal) and NRGN (Neurogranin). Furthermore, a gene coding for a calcium channel subunit (CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit) is discussed in the light of schizophrenia whereas genetic findings related to alterations in the intracellular Ca-homeostasis associated specifically with dopaminergic and serotonergic neurotransmission in schizophrenia are not herein closer reviewed. Taken together there is converging evidence for the contribution of genes potentially related to alterations in intracellular Ca-homeostasis to the risk of schizophrenia. Replications and functional studies will hopefully provide further insight into these genetic variants and the underlying processes.

Distribution and characteristics of D-amino acid and D-aspartate oxidases in fish tissues.

The distributions of D-amino acid oxidase (D-AAO, EC 1.4.3.3) and D-aspartate oxidase (D-AspO, EC 1.4.3.1) activities were examined on several tissues of various fish species. Both enzyme activities were commonly high in kidney and liver and low in intestine with some exceptions. After oral administration of D-alanine at 5 micromol /g body weight(-1)day(-1) to carp for 30 days, D-AAO activity increased by about 8-, 3-, and 1.5-fold in intestine, hepatopancreas, and kidney, respectively, whereas no increase was found in brain. In contrast, oral administration of D-glutamate or D-aspartate did not show any increase of D-AspO activity in any tissues. D-AAO and D-AspO of common carp kidney and hepatopancreas were subcellularly localized in peroxisomes, as clarified in mammals. D-proline was the best substrate for D-AAO in rainbow trout kidney, common carp kidney, and hepatopancreas, followed by D-alanine and D-phenylalanine. N-methyl-D-aspartate was the best substrate for D-AspO in rainbow trout kidney and common carp hepatopancreas. The optimal pH for D-AAO in rainbow trout kidney was broad, from 7.4 to 8.2, and that for D-AspO was around 10. D-AAO was inhibited by benzoate known as D-AAO inhibitor and D-AspO was strongly inhibited by meso-tartarate as D-AspO inhibitor. From these results, at least D-AAO in fish is considered to work as a metabolizing agent of exogenous and endogenous free D-alanine that is abundant in aquatic invertebrates such as crustaceans and bivalve mollusks, which are potential food sources of these fishes.